tiprankstipranks
Recordati Industria Chimica e Farmaceutica SPA (RCDTF)
OTHER OTC:RCDTF
US Market

Recordati Industria Chimica e Farmaceutica SPA (RCDTF) Financial Statements

Compare
18 Followers

Recordati Industria Chimica e Farmaceutica SPA Financial Overview

Recordati Industria Chimica e Farmaceutica SPA's market cap is currently €11.84B. The company's EPS TTM is $2.226; its P/E ratio is 25.69; and it has a dividend yield of 2.32%. Recordati Industria Chimica e Farmaceutica SPA is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 2.34B€ 2.08B€ 1.85B€ 1.58B€ 1.45B
Gross Profit€ 1.64B€ 1.42B€ 1.29B€ 1.15B€ 1.04B
Operating Income€ 638.90M€ 558.01M€ 437.33M€ 490.19M€ 469.02M
EBITDA€ 857.80M€ 708.16M€ 559.35M€ 578.35M€ 566.83M
Net Income€ 416.50M€ 389.21M€ 312.34M€ 385.97M€ 354.98M
Balance Sheet
Cash & Short-Term Investments€ 235.02M€ 221.81M€ 284.73M€ 244.58M€ 188.23M
Total Assets€ 0.00€ 4.21B€ 4.00B€ 2.82B€ 2.71B
Total Debt€ 0.00€ 1.81B€ 1.72B€ 992.19M€ 1.06B
Net Debt€ 0.00€ 1.59B€ 1.43B€ 747.61M€ 872.83M
Total Liabilities€ -1.88B€ 2.52B€ 2.45B€ 1.43B€ 1.44B
Stockholders' Equity€ 1.88B€ 1.69B€ 1.55B€ 1.38B€ 1.28B
Cash Flow
Free Cash Flow€ 535.10M€ 102.06M€ 365.35M€ 404.29M€ 271.90M
Operating Cash Flow€ 569.90M€ 485.32M€ 461.69M€ 491.65M€ 403.57M
Investing Cash Flow€ -63.20M€ -379.62M€ -767.12M€ -87.50M€ -131.56M
Financing Cash Flow€ -406.10M€ -168.91M€ 341.28M€ -355.94M€ -264.29M
Currency in EUR

Recordati Industria Chimica e Farmaceutica SPA Earnings and Revenue History

Recordati Industria Chimica e Farmaceutica SPA Debt to Assets

Recordati Industria Chimica e Farmaceutica SPA Cash Flow

Recordati Industria Chimica e Farmaceutica SPA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis